• 1. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 2. An atmosphere and light tuned highly diastereoselective synthesis of cyclobuta/penta[b]indoles from aniline-tethered alkylidenecyclopropanes with alkynes?
  Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873
• 3. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 4. An Aptamer Bio-barCode (ABC) assay using SPR, RNase H, and probes with RNA and gold-nanorods for anti-cancer drug screening
  Chengbin Yang,Hing Lun Tsang,Pui Man Lau,Ken-Tye Yong,Ho Pui Ho,Siu Kai Kong Analyst, 2017,142, 3579-3587
• 5. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383

Introduction to 6-Fluoro-5-nitro-1H-indazole (CAS No: 633327-51-2)

6-Fluoro-5-nitro-1H-indazole, identified by its Chemical Abstracts Service (CAS) number 633327-51-2, is a heterocyclic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the indazole family, which is well-known for its diverse biological activities and potential applications in drug development. The presence of both fluoro and nitro substituents in its molecular structure imparts unique chemical and pharmacological properties, making it a valuable scaffold for further chemical modifications and biological evaluations.

The structural features of 6-Fluoro-5-nitro-1H-indazole include a nitrogen-containing indazole ring system, which is a common motif in many bioactive molecules. The fluorine atom at the 6-position and the nitro group at the 5-position are particularly noteworthy, as they can influence the compound's electronic properties, metabolic stability, and binding affinity to biological targets. These substituents are often strategically incorporated into drug candidates to enhance their pharmacokinetic profiles and therapeutic efficacy.

In recent years, there has been a growing interest in indazole derivatives due to their broad spectrum of biological activities. Studies have demonstrated that compounds containing the indazole scaffold exhibit properties such as antimicrobial, antiviral, anti-inflammatory, and anticancer effects. The introduction of fluorine and nitro groups into these molecules has further expanded their potential therapeutic applications. For instance, fluorinated indazoles have shown improved bioavailability and metabolic stability, while nitro-substituted derivatives often exhibit enhanced reactivity and binding interactions with biological targets.

One of the most compelling aspects of 6-Fluoro-5-nitro-1H-indazole is its versatility as a chemical intermediate. Researchers have leveraged this compound to synthesize novel derivatives with tailored biological activities. The fluoro group, in particular, is known for its ability to modulate drug-receptor interactions, leading to improved pharmacological outcomes. Similarly, the nitro group can serve as a handle for further functionalization, allowing chemists to explore new chemical spaces and discover innovative therapeutic agents.

The pharmacological profile of 6-Fluoro-5-nitro-1H-indazole has been the subject of several recent studies. Research has indicated that this compound exhibits promising activity against various disease targets. For example, studies have shown that it may have potential in inhibiting certain enzymes involved in cancer cell proliferation. Additionally, its ability to interact with specific protein targets has been explored in the context of developing treatments for infectious diseases. These findings highlight the compound's significance as a lead molecule in drug discovery efforts.

The synthesis of 6-Fluoro-5-nitro-1H-indazole involves multi-step organic reactions that require careful optimization to ensure high yield and purity. The introduction of the fluoro and nitro substituents necessitates precise control over reaction conditions to avoid unwanted side products. Advances in synthetic methodologies have enabled more efficient and scalable production processes for this compound, making it more accessible for research purposes.

In conclusion, 6-Fluoro-5-nitro-1H-indazole (CAS No: 633327-51-2) is a structurally interesting and biologically relevant compound with significant potential in pharmaceutical research. Its unique combination of fluorine and nitro substituents makes it a valuable scaffold for developing novel therapeutic agents. As research continues to uncover new applications for this compound, it is likely to remain a key player in the discovery and development of next-generation drugs.

• 65750-01-8(2H-Indazole, 5-nitro-)
• 1105175-05-0(7-Fluoro-5-nitro-1H-indazole)
• 1360952-20-0(5-Fluoro-6-nitro-1H-indazole)
• 5401-94-5(5-nitro-1H-indazole)
• 1167056-02-1(5-Fluoro-7-nitro 1h-indazole)
• 864082-72-4(1H-INDAZOLE, 3-CHLORO-6-FLUORO-5-NITRO-)
• 866144-02-7(4-Fluoro-7-nitro-1H-indazole)
• 885520-14-9(6-Fluoro-4-nitro-1H-indazole)
• 885520-01-4(4-Fluoro-6-nitro-1H-indazole)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)